Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Azad

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 5, 2024
Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasisHeng-Chung Kung, Christopher Shubert, Catherine Wilbur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid CancersRazelle Kurzrock, Douglas W Ball, Marianna L Zahurak, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 22, 2021
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer ClinicAngela Y Jia, Aleksandra Popovic, Aditya A Mohan, et al.
Clinical Epigenetics|February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpointKatherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Cancer Research Communications|October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsTheron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Hepatology (Baltimore, Md.)|December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinomaDaniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Cancer Research Communications|March 2, 2023
Phase I Trial of Intravenous Mistletoe Extract in Advanced CancerChanning J Paller, Lin Wang, Wei Fu, et al.
Surgery Open Science|February 6, 2024
Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancerI-Chia Liu, Susan Gearhart, Suqi Ke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activityNilofer S Azad, Edwin M Posadas, Virginia E Kwitkowski, et al.
The Lancet. Oncology|August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket studyMilind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 5, 2024
Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasisHeng-Chung Kung, Christopher Shubert, Catherine Wilbur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid CancersRazelle Kurzrock, Douglas W Ball, Marianna L Zahurak, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 22, 2021
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer ClinicAngela Y Jia, Aleksandra Popovic, Aditya A Mohan, et al.
Clinical Epigenetics|February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpointKatherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Cancer Research Communications|October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsTheron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Hepatology (Baltimore, Md.)|December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinomaDaniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Cancer Research Communications|March 2, 2023
Phase I Trial of Intravenous Mistletoe Extract in Advanced CancerChanning J Paller, Lin Wang, Wei Fu, et al.
Surgery Open Science|February 6, 2024
Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancerI-Chia Liu, Susan Gearhart, Suqi Ke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activityNilofer S Azad, Edwin M Posadas, Virginia E Kwitkowski, et al.
The Lancet. Oncology|August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket studyMilind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Pageof 20